Page last updated: 2024-10-22

alpha-cyano-4-hydroxycinnamate and Colorectal Neoplasms

alpha-cyano-4-hydroxycinnamate has been researched along with Colorectal Neoplasms in 1 studies

alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nelson, GL1
Ronayne, CT1
Solano, LN1
Jonnalagadda, SK1
Jonnalagadda, S1
Rumbley, J1
Holy, J1
Rose-Hellekant, T1
Drewes, LR1
Mereddy, VR1

Other Studies

1 other study available for alpha-cyano-4-hydroxycinnamate and Colorectal Neoplasms

ArticleYear
Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment.
    Scientific reports, 2019, 12-04, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cinnamates; Colorectal Neoplas

2019